Orion, the Finnish pharmaceuticals company, delivered a strong performance in the third quarter of 2010, marking a significant increase in profit before taxes to EUR 70.0 mn, up from EUR 54.9 mn in the corresponding period in 2009. This growth reflects a positive trend for the company, signaling increased financial strength and market confidence.